Wordt geladen...

Post-licensure safety surveillance of 23-valent pneumococcal polysaccharide vaccine in the Vaccine Adverse Event Reporting System (VAERS), 1990–2013

BACKGROUND: 23-Valent pneumococcal polysaccharide vaccine, trade name Pneumovax(®)23 (PPSV23), has been used for decades in the Unites States and has an extensive clinical record. However, limited post-licensure safety assessment has been conducted. OBJECTIVE: To analyze reports submitted to the Vac...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Vaccine
Hoofdauteurs: Miller, Elaine R., Moro, Pedro L., Cano, Maria, Lewis, Paige, Bryant-Genevier, Marthe, Shimabukuro, Tom T.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2016
Onderwerpen:
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6546117/
https://ncbi.nlm.nih.gov/pubmed/27087150
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2016.04.021
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!